Search
Mersana Therapeutics Inc
MRSNAdd to Watchlist
29.080USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
145.36MMarket Cap
LossP/E TTM
Mersana Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-01-05The current valuation score of Mersana Therapeutics Inc is 7.29, ranking 146 out of 401 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.07, which is -99.16% below the recent high of -0.02 and -0.07% above the recent low of -2.07.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.